Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications
- 11 March 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 4 (5), 285-293
- https://doi.org/10.1038/ncpendmet0786
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– miceJCI Insight, 2008
- NADPH Oxidase Contributes to Vascular Inflammation, Insulin Resistance, and Remodeling in the Transgenic (mRen2) RatHypertension, 2007
- Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stressJournal of Leukocyte Biology, 2007
- Inhibition of Diabetic Leukostasis and Blood-Retinal Barrier Breakdown with a Soluble Form of a Receptor for Advanced Glycation End ProductsInvestigative Ophthalmology & Visual Science, 2007
- Blockade of RAGE Suppresses Alloimmune Reactions In Vitro and Delays Allograft Rejection in Murine Heart TransplantationAmerican Journal of Transplantation, 2007
- Activation of RAGE induces elevated O2− generation by mononuclear phagocytes in diabetesJournal of Leukocyte Biology, 2006
- The RAGE Axis in Early Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2005
- Angiotensin II augments advanced glycation end product‐induced pericyte apoptosis through RAGE overexpressionFEBS Letters, 2005
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993